LicianPro

CRBP holders · GOLDMAN SACHS GROUP INC 13F · CRBP stock

GOLDMAN SACHS GROUP INC Corbus Pharmaceuticals Holding (CRBP) 13F holding

GOLDMAN SACHS GROUP INC reported 93,111 CRBP shares valued at $874.3K as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest CRBP 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the CRBP holders table.

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.